Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples